Facebook tracking pixel
S10.AI
ICD-10-CM · N92.6GeneralSystemic

Abnormal Menstrual Bleeding

Understand Abnormal Menstrual Bleeding (Menorrhagia) with comprehensive information for healthcare professionals. This resource covers clinical documentation, medical coding, and Irregular Menstrual Bleeding, including Heavy Menstrual Bleeding, for accurate diagnosis and patient care. Learn about Menorrhagia symptoms, causes, and treatment options relevant to healthcare providers and coding specialists.

Also known as
MenorrhagiaIrregular Menstrual BleedingHeavy Menstrual Bleeding
Definition

Vaginal bleeding outside of normal menstruation, including heavy, prolonged, or frequent bleeding.

Clinical signs

Heavy flow soaking through pads hourly, prolonged periods (7+ days), bleeding between periods, anemia symptoms.

Common settings

Primary care, gynecology, family planning clinics. Treatment depends on underlying cause.

Related Codes

ICD-10 Code Families

Complete code families applicable to N92.6

N92-N92
Excessive, frequent, and irregular menstruation
N93-N93
Other abnormal bleeding from female genital tract
R31-R31
Unspecific hematuria
Code Comparison

When to use each related code

DescriptionWhen to use
Heavy or prolonged menstrual bleeding.Use for objectively heavy bleeding or prolonged menses disrupting normal activities. Consider underlying causes.
Bleeding between periods.Use for bleeding occurring between regular menses. Exclude spotting related to ovulation or hormonal contraception.
Absent menstrual periods.Use for the absence of menses. Specify primary or secondary amenorrhea and investigate underlying etiology.
Documentation

Best-practice checklist

  • Document cycle length & regularity.
  • Quantify blood loss (e.g., pad counts).
  • Describe bleeding pattern (e.g., clots).
  • Rule out other causes (e.g., fibroids).
  • Document impact on quality of life.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Bleeding

Coding menorrhagia as unspecified abnormal uterine bleeding (AUB) without sufficient documentation leads to inaccurate severity reflection and potential downcoding.

Lack of Specificity

Failing to document the cause, frequency, and duration of bleeding affects accurate code assignment (e.g., menorrhagia vs. metrorrhagia) and reimbursement.

Missed Comorbidities

Overlooking associated conditions like fibroids or coagulopathies during coding and auditing can lead to incomplete clinical picture and missed CC/MCC capture.

Mitigation

Best-practice tips

  • 01Document cycle length, regularity, and flow characteristics using standardized terminology.
  • 02Code accurately using ICD-10 AUB codes (e.g., N92.0, N92.1) based on documented characteristics.
  • 03Query physician for clarification if documentation lacks specificity for accurate coding and diagnosis.
  • 04Educate patients about menstrual health and encourage tracking to facilitate early identification of AUB.
  • 05Consider endometrial biopsy for prolonged or heavy bleeding to rule out underlying malignancy for compliant CDI.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm diagnosis: Abnormal Menstrual Bleeding (ICD-10 N92.x, N93.x)

  2. 2

    Document cycle frequency, duration, and flow volume.

  3. 3

    Assess for anemia (CBC, iron studies).

  4. 4

    Consider pregnancy test if applicable.

  5. 5

    Evaluate for underlying causes (e.g., fibroids, PCOS).

Documentation Template

Ready-to-paste narrative

Patient presents with complaints consistent with abnormal menstrual bleeding (AMB).  The patient describes [frequency, duration, and flow of menses; e.g., prolonged menses lasting greater than seven days, heavy menstrual bleeding with soaking through one or more pads or tampons per hour, or irregular menstrual cycles].  She reports [associated symptoms, e.g.,  intermenstrual bleeding,  dysmenorrhea, pelvic pain, fatigue, or shortness of breath].  Menorrhagia is suspected as a primary diagnosis, though other potential causes of irregular menstrual bleeding, including [list differentials; e.g.,  fibroids, adenomyosis, endometrial polyps, coagulopathy, or hormonal imbalances], are being considered.  A detailed menstrual history was obtained, including menarche age, cycle length and regularity, and history of prior abnormal uterine bleeding episodes.  Physical examination revealed [relevant findings; e.g., normal pelvic exam, pale conjunctiva, or uterine tenderness].  Initial laboratory studies were ordered, including a complete blood count (CBC) to assess for anemia, coagulation studies to rule out bleeding disorders, and thyroid stimulating hormone (TSH) to evaluate thyroid function.  Depending on the lab results and further clinical assessment, additional investigations, such as pelvic ultrasound, endometrial biopsy, or hormonal testing, may be indicated.  Patient education was provided regarding potential causes, diagnostic procedures, and management options for heavy menstrual bleeding.  Treatment options will be discussed after further diagnostic workup and will be tailored to the underlying cause of the AMB. This may include medical management with hormonal therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), or tranexamic acid, or procedural interventions such as dilation and curettage (D&C) or endometrial ablation. The patient was advised to schedule a follow-up appointment to review the results and discuss the next steps in her care plan.  ICD-10 code N92.0 (Excessive and frequent menstruation) is considered for billing purposes, subject to confirmation following completion of diagnostic evaluation.
FAQs

Common questions and answers

What are the most effective diagnostic approaches for differentiating between common causes of abnormal uterine bleeding (AUB), such as leiomyomas, adenomyosis, and endometrial hyperplasia in perimenopausal women?+

Diagnosing the underlying cause of abnormal uterine bleeding (AUB), especially in perimenopausal women, requires a multi-faceted approach. Transvaginal ultrasound is often the first-line imaging modality, offering good visualization of uterine fibroids (leiomyomas) and assessing endometrial thickness. However, it may not always clearly distinguish between adenomyosis and other conditions. MRI offers superior soft tissue contrast and can be valuable in differentiating adenomyosis from leiomyomas and other pathologies. Endometrial biopsy, guided by hysteroscopy or performed blindly, is crucial for excluding endometrial hyperplasia or malignancy, particularly in women with risk factors like obesity or unopposed estrogen exposure. Consider implementing a diagnostic algorithm that combines these modalities based on individual patient risk factors and initial findings. Explore how a combination of imaging and histopathology can enhance diagnostic accuracy in complex AUB cases. Learn more about the latest ACOG guidelines for managing AUB in perimenopausal women.

How can I effectively manage heavy menstrual bleeding (menorrhagia) in a patient with von Willebrand disease while minimizing treatment risks?+

Managing menorrhagia in patients with von Willebrand disease (VWD) requires a careful balance between controlling bleeding and minimizing potential complications. First-line therapy often includes combined oral contraceptives or hormonal IUDs to regulate the menstrual cycle and reduce bleeding volume. Tranexamic acid can be used as an adjunctive therapy during menses to further control bleeding. Desmopressin (DDAVP) may be considered for some VWD subtypes, but it carries a risk of hyponatremia and should be used cautiously with appropriate monitoring. For patients unresponsive to these measures, consider referral to a hematologist specializing in bleeding disorders. Explore how individualized treatment plans can address the specific needs and VWD subtype of your patient. Learn more about the current guidelines for managing VWD and menorrhagia.

What are the best practices for evaluating and managing irregular menstrual bleeding in adolescents, considering potential underlying causes like PCOS and thyroid dysfunction?+

Evaluating irregular menstrual bleeding in adolescents requires a thorough history and physical exam, focusing on pubertal development, body mass index, and associated symptoms. Initial laboratory tests should include a complete blood count, thyroid function tests, and possibly prolactin levels to rule out common endocrine disorders. Pelvic ultrasound may be indicated if there are concerns about structural abnormalities or persistent irregularities. If Polycystic Ovary Syndrome (PCOS) is suspected based on clinical presentation and/or ultrasound findings, consider further evaluation of androgen levels. Management often includes lifestyle modifications like diet and exercise, and hormonal therapy with combined oral contraceptives can help regulate menstrual cycles and address associated symptoms like acne or hirsutism. Explore how early intervention and appropriate management strategies can improve long-term outcomes for adolescents with irregular menstrual bleeding. Consider implementing a staged approach to evaluation based on the patient's specific symptoms and risk factors. Learn more about the latest adolescent gynecology guidelines for managing irregular menses.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.